Turner, W.M.; Tuminello, S.; Untalan, M.; Flores, R.; Taioli, E.
Incongruence Between Prerequisite Molecular Testing and Treatment with Personalized Therapies for Non-Small Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study. Int. J. Mol. Sci. 2025, 26, 4581.
https://doi.org/10.3390/ijms26104581
AMA Style
Turner WM, Tuminello S, Untalan M, Flores R, Taioli E.
Incongruence Between Prerequisite Molecular Testing and Treatment with Personalized Therapies for Non-Small Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study. International Journal of Molecular Sciences. 2025; 26(10):4581.
https://doi.org/10.3390/ijms26104581
Chicago/Turabian Style
Turner, Wiley M., Stephanie Tuminello, Matthew Untalan, Raja Flores, and Emanuela Taioli.
2025. "Incongruence Between Prerequisite Molecular Testing and Treatment with Personalized Therapies for Non-Small Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study" International Journal of Molecular Sciences 26, no. 10: 4581.
https://doi.org/10.3390/ijms26104581
APA Style
Turner, W. M., Tuminello, S., Untalan, M., Flores, R., & Taioli, E.
(2025). Incongruence Between Prerequisite Molecular Testing and Treatment with Personalized Therapies for Non-Small Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare Study. International Journal of Molecular Sciences, 26(10), 4581.
https://doi.org/10.3390/ijms26104581
